Instalab

3-Indoleacetic Acid

Urine Test
Get an early read on how your gut microbes are processing tryptophan, a window standard labs do not open.

Should you take a 3-Indoleacetic Acid test?

This test is most useful if any of these apply to you.

Watching Your Kidney Health
You want a deeper look at how your kidneys handle organic waste molecules, beyond what creatinine and eGFR show.
Working on Your Gut Microbiome
You use diet, fiber, or probiotics to shift your microbiome and want a metabolic readout of whether your microbes are responding.
Building a Longitudinal Profile
You track multiple biomarkers over time and want an exploratory window into tryptophan metabolism that standard panels do not open.
Optimizing Diet and Body Composition
You are addressing body composition or chronic low-grade inflammation and want to see how gut microbial metabolism tracks with your changes.

About 3-Indoleacetic Acid

Your gut bacteria are constantly converting the tryptophan in your food into a family of small molecules called indoles. One of them, 3-IAA (3-indoleacetic acid), shows up in your urine and offers a glimpse into how that conversation between your microbes, your kidneys, and the rest of your body is going.

This is an exploratory marker, not a routine clinical test. There are no standardized cutoffs yet, but the signal it carries touches kidney function, gut microbial activity, and how your body handles acid loads. Watching how your level shifts over time gives you a head start on understanding patterns that standard panels cannot see.

What This Molecule Actually Is

3-IAA is a tryptophan-derived metabolite produced almost entirely by gut bacteria such as Bacteroides, Bifidobacteria, and Eubacteria. Your own cells are not thought to make meaningful amounts of it. Once produced in the gut, it enters the bloodstream, gets modified by the liver, and is cleared into the urine through active tubular secretion by kidney transport proteins called OAT1 and OAT3 (kidney transporters that actively push certain waste molecules into urine).

Because it sits at the crossroads of diet, gut microbes, liver processing, and kidney clearance, urine 3-IAA is a composite signal. A change in any of those four systems can move the number, which is part of why interpretation requires context rather than a single threshold.

Kidney Function and Acid-Base Handling

The clearest human evidence for urine 3-IAA comes from kidney research. In a controlled crossover trial of patients with and without chronic kidney disease (CKD), bicarbonate (alkali) supplementation significantly raised urinary 3-indoleacetate, along with citrate, isocitrate, and glutarate. These molecules act as conjugate bases, meaning they help neutralize acid loads the kidney is trying to clear.

The interpretation is that urine 3-IAA partly reflects how well your kidneys are excreting organic anions to buffer acid. In CKD specifically, higher urinary 3-indoleacetate after alkali therapy was read as a sign of greater capacity to participate in acid-base compensation.

The Uremic Toxin Side of the Story

3-IAA has a dual identity. In the blood of people with reduced kidney function, it behaves as a protein-bound uremic toxin (a waste molecule that sticks to blood proteins and is hard to remove with dialysis). At higher circulating levels it has been linked to oxidative stress (cell damage from unstable molecules) in kidney cells, endothelial inflammation, increased tissue factor (a clotting trigger), and higher risk of thrombotic events and mortality in CKD populations.

This creates an apparent paradox: the same molecule that signals acid-base compensation in urine can signal harm when it accumulates in blood. The framework that resolves this is straightforward. 3-IAA is not a 'good number, bad number' marker. What matters is where it is building up and why. A healthy kidney clears it efficiently into urine. A failing kidney lets it accumulate systemically. The urine reading mostly reflects clearance and microbial production; the blood reading reflects retention.

Gut Microbial Activity and Body Composition

In a longitudinal study of 218 young people, long-term overweight in males was associated with lower urinary 3-IAA. The interpretation is that excess body fat changes how gut microbes process tryptophan, and that this shift may contribute to the low-grade inflammation that tracks with obesity.

In a separate metabolomic study of young children with autism, urinary 3-IAA was elevated as part of a broader tryptophan and gut dysbiosis signature. These two findings point in opposite directions, which is the rule rather than the exception for microbiome-linked markers. Urine 3-IAA is best read as one strand of a larger pattern of microbial metabolism rather than as a stand-alone verdict on gut health.

Cancer Detection Panels

In a study of West African participants, a urine panel that included inosine, indole-3-acetate, galactose, and an N-acetylated amino acid detected hepatocellular carcinoma against a background of cirrhosis with high sensitivity and specificity, outperforming the standard blood test for this cancer, AFP (alpha-fetoprotein).

In a separate panel for central precocious puberty, urinary 3-IAA contributed to a six-metabolite model that distinguished cases from controls with high sensitivity and specificity. In both settings, 3-IAA is one ingredient in a recipe, not the recipe itself. Its diagnostic value emerges in combination with other metabolites, which is consistent with how exploratory markers typically earn their clinical place.

Why a Single Reading Is Not Enough

Urine metabolites generally show meaningful within-person variability. One study using NMR (nuclear magnetic resonance, a method for measuring multiple metabolites at once) profiling of children's urine found that more than half of the variance in metabolite levels was specific to the individual, with the rest driven by daily fluctuations. Translation: your number today is not your number forever, and a single snapshot can mislead.

A practical plan: get a baseline reading. If you are actively changing your diet, adjusting fiber intake, taking a probiotic, or addressing kidney function, retest in 3 to 6 months to see whether your trend is moving. After that, an annual reading is a reasonable cadence for tracking. The trajectory matters more than any single value, especially with an exploratory marker that does not yet have standardized cutoffs.

When Results Can Be Misleading

Several factors can distort a single urine 3-IAA reading without reflecting any meaningful change in your underlying biology.

  • Recent diet: cruciferous vegetables (broccoli, cabbage, Brussels sprouts) and tryptophan-rich foods can transiently raise urinary 3-IAA and its conjugates through direct dietary input and microbial conversion.
  • Kidney clearance shifts: urine 3-IAA depends on active tubular secretion through the OAT1 and OAT3 transporters. Anything that changes how these transporters work, including dehydration or acute changes in kidney function, can shift the number without indicating disease.
  • Within-person variability: more than half of the variance in urine metabolite profiles is individual-specific in human studies, meaning your level can drift day to day even when nothing meaningful has changed.
  • Microbiome perturbations: a recent course of antibiotics or a sudden shift in fiber intake can change the gut microbes that produce 3-IAA, moving urinary levels for reasons that have nothing to do with kidney or systemic health.

What to Do With an Out-of-Pattern Result

Because this is an exploratory marker, a single unexpected reading is not a diagnosis. The right move is to read it in context. If urine 3-IAA is unusually low or high, the most useful next step is to look at it alongside markers of kidney function (cystatin C, eGFR, urine albumin-to-creatinine ratio) and broader metabolic and inflammatory markers (hs-CRP, fasting glucose, lipid panel).

If your kidney markers are also off, a nephrologist can help interpret whether the pattern reflects early changes in tubular secretion or acid-base handling. If kidney function looks normal but the value is persistently unusual across two readings spaced months apart, the more likely explanation is a microbiome or dietary pattern. A gastroenterologist or registered dietitian who works with gut health can help map next steps. Watchful waiting with a planned retest is reasonable when a single result is out of pattern and everything else looks normal.

How to Collect the Sample

Most urine metabolomic panels use either a first-morning void or a 24-hour collection. Follow the specific instructions in your kit. The most common collection errors are incomplete 24-hour samples (forgetting one void can substantially change concentrations) and contaminating spot samples with food residue or skin cells. Avoid alcohol and intense exercise in the day before testing, and keep your usual diet stable for at least 48 hours so the result reflects your baseline rather than a recent meal.

What Moves This Biomarker

Evidence-backed interventions that affect your 3-Indoleacetic Acid level

Increase
Bicarbonate (alkali) supplementation in chronic kidney disease
In adults with CKD, taking bicarbonate raises urinary 3-indoleacetate as part of an increase in organic anion excretion that helps your kidneys buffer acid loads. In a controlled crossover trial that quantified urine metabolites in CKD patients, bicarbonate supplementation significantly raised urinary 3-indoleacetate, along with citrate, isocitrate, and glutarate, compared to sodium chloride control.
MedicationModerate Evidence
Increase
Eating cruciferous vegetables (broccoli, cabbage, Brussels sprouts)
Cruciferous vegetable intake raises labeled indole-3-acetic acid and its conjugated form (indole-3-acetic acid-N-O-glucuronide) in urine within hours to days of consumption. In a metabolomic study of adults using stable isotope tracing, these compounds appeared in urine as direct biomarkers of cruciferous vegetable consumption.
DietModerate Evidence
Decrease
Sustained overweight body composition
In young males, long-term overweight was linked to lower urinary indole-3-acetic acid, suggesting altered gut microbial tryptophan metabolism that may contribute to obesity-related inflammation. The shift was observed across multiple time points rather than from a single snapshot.
LifestyleModerate Evidence

Frequently Asked Questions

Panels containing 3-Indoleacetic Acid

3-Indoleacetic Acid is included in these pre-built panels.

References

11 studies
  1. Reshetova M, Markin P, Appolonova S, Yunusov I, Zolnikova O, Bueverova E, Dzhakhaya N, Zharkova M, Poluektova E, Maslennikov R, Ivashkin VBiomolecules2024
  2. Nemutlu E, Ozaltın F, Yabanoglu-ciftci S, Gulhan B, Eylem CC, Baysal İ, Gök-topak E, Ulubayram K, Sezerman OU, Ucar G, Kır S, Topaloğlu RInternational Journal of Molecular Sciences2023
  3. Watanabe H, Miyamoto Y, Otagiri M, Maruyama TJournal of Pharmaceutical Sciences2011
  4. Tyson CC, Luciano a, Modliszewski J, Corcoran D, Bain J, Muehlbauer M, Ilkayeva O, Pourafshar S, Allen J, Bowman C, Gung J, Asplin J, Pendergast J, Svetkey L, Lin P, Scialla JAmerican Journal of Kidney Diseases2021
  5. Cernaro V, Calabrese V, Loddo S, Corsaro R, Macaione V, Ferlazzo VT, Cigala RM, Crea F, De Stefano C, Gembillo G, Romeo a, Longhitano E, Santoro D, Buemi M, Benvenga SNephrology Dialysis Transplantation2021